Correlation Between OS Therapies and Centessa Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both OS Therapies and Centessa Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining OS Therapies and Centessa Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between OS Therapies Incorporated and Centessa Pharmaceuticals PLC, you can compare the effects of market volatilities on OS Therapies and Centessa Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in OS Therapies with a short position of Centessa Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of OS Therapies and Centessa Pharmaceuticals.

Diversification Opportunities for OS Therapies and Centessa Pharmaceuticals

-0.05
  Correlation Coefficient

Good diversification

The 3 months correlation between OSTX and Centessa is -0.05. Overlapping area represents the amount of risk that can be diversified away by holding OS Therapies Incorporated and Centessa Pharmaceuticals PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Centessa Pharmaceuticals and OS Therapies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on OS Therapies Incorporated are associated (or correlated) with Centessa Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Centessa Pharmaceuticals has no effect on the direction of OS Therapies i.e., OS Therapies and Centessa Pharmaceuticals go up and down completely randomly.

Pair Corralation between OS Therapies and Centessa Pharmaceuticals

Given the investment horizon of 90 days OS Therapies Incorporated is expected to under-perform the Centessa Pharmaceuticals. In addition to that, OS Therapies is 2.41 times more volatile than Centessa Pharmaceuticals PLC. It trades about -0.13 of its total potential returns per unit of risk. Centessa Pharmaceuticals PLC is currently generating about -0.01 per unit of volatility. If you would invest  1,716  in Centessa Pharmaceuticals PLC on December 20, 2024 and sell it today you would lose (87.00) from holding Centessa Pharmaceuticals PLC or give up 5.07% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

OS Therapies Incorporated  vs.  Centessa Pharmaceuticals PLC

 Performance 
       Timeline  
OS Therapies 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days OS Therapies Incorporated has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Centessa Pharmaceuticals 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Centessa Pharmaceuticals PLC has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Centessa Pharmaceuticals is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

OS Therapies and Centessa Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with OS Therapies and Centessa Pharmaceuticals

The main advantage of trading using opposite OS Therapies and Centessa Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if OS Therapies position performs unexpectedly, Centessa Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Centessa Pharmaceuticals will offset losses from the drop in Centessa Pharmaceuticals' long position.
The idea behind OS Therapies Incorporated and Centessa Pharmaceuticals PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance